Physician profile
Mark D Williams
NPI 1659451938
$2,729.95
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2020: $225 · 2021: $276 · 2022: $113 · 2023: $548 · 2024: $67.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $466 · Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $466.49 |
| Food and Beverage | $149.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Kerr Corporation | $425.54 | 2021-2023 | Optibond Universal, Simplishade |
| Ultradent Products INC | $266.64 | 2020-2022 | |
| Ivoclar Vivadent, INC. | $176.38 | 2020-2021 | |
| Zimvie INC. | $135.56 | 2023 | |
| Septodont INC. | $127.02 | 2020-2024 | Bioroot Flow (Sample) |
| Biohorizons Implant Systems INC. | $39.08 | 2021 | |
| Zimmer Biomet Holdings, INC. | $33.48 | 2020 | |
| Solventum Corporation | $13.56 | 2024 | 3m Scotchbond, 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Dentsply Sirona INC | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.